Related Experiment Video

Updated: Aug 22, 2026

Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software
07:32

Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software

Published on: April 12, 2024

Reduced expression of cell cycle regulator p18(INK4C) in human hepatocellular carcinoma

Asahiro Morishita1, Tsutomu Masaki, Hitoshi Yoshiji

  • 1Third Department of Internal Medicine, Kagawa Medical University, Kagawa, Japan.

Hepatology (Baltimore, Md.)
|September 7, 2004
PubMed

Insights

Loss of p18INK4C expression is frequent in hepatocellular carcinoma (HCC), particularly in poorly differentiated tumors. This loss correlates with poor prognosis and increased Cdk4 activity, suggesting a role in HCC development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Cyclins, cyclin-dependent kinases (Cdks), and Cdk inhibitors (CdkIs) are crucial regulators of the cell cycle.
  • Alterations in these proteins are common in human cancers, including hepatocellular carcinoma (HCC).
  • p18INK4C, an INK4 family Cdk inhibitor, is a potential tumor suppressor, but its role in HCC is not well understood.

Purpose of the Study:

  • To investigate the expression patterns of p18INK4C in various liver diseases, with a focus on HCC.
  • To evaluate the clinical significance of p18INK4C expression in HCC.
  • To explore the relationship between p18INK4C, retinoblastoma protein (pRb) phosphorylation, and the activity of Cdk4 and Cdk6 in HCC.

Main Methods:

  • Immunohistochemistry was employed to assess p18INK4C expression in 51 HCC samples and other liver diseases.
  • The study analyzed the correlation between p18INK4C expression levels and clinicopathological features.
  • Western blotting or kinase assays were used to measure Cdk4/Cdk6 activity and pRb phosphorylation.

Main Results:

  • Frequent loss of p18INK4C expression was observed in HCC, especially in poorly differentiated tumors.
  • Loss of p18INK4C was significantly associated with a poorer prognosis in HCC patients.
  • p18INK4C-negative HCCs exhibited higher Cdk4 kinase activity and increased pRb phosphorylation compared to p18INK4C-positive HCCs.

Conclusions:

  • The loss of p18INK4C expression may contribute to the development and progression of HCC.
  • This loss appears to be linked to the dysregulation of Cdk4 activity, leading to increased cell proliferation.
  • p18INK4C serves as a potential tumor suppressor in HCC, and its expression level is a significant prognostic marker.

More Related Videos

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines08:50

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines

Published on: April 18, 2025

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...